Form 4 for NVCR NovoCure Ltd
Accepted 2022-08-04 00:00:00 ET · period of report 2022-08-03 · accession 0001645113-22-000073 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-08-04 | 2022-08-03 | NVCR | Benaim Ely | Chief Medical Off | S - Sale | $73.73 | -5,959 | 28.7K | -17% | -$439.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2022-08-03 | S | D | 563 | $71.09 | 34,068 | D | — | — | (F1) Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Dr. Benaim. |
| 2 | Common | Ordinary Shares | 2022-08-03 | S | D | 5,396 | $74.00 | 28,672 | D | — | — |